SEC Form 4 · accession 0001562180-15-000726
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Stambaugh
Officer — VP Clinical Affairs
Period of report
Sep 2, 2015
Accepted (ET)
Sep 4, 2015 · 10:53 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 2, 2015 | M | 4,000 | $0.48 | A | 4,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.48 | Sep 2, 2015 | M | 4,000 | D | — | Nov 16, 2016 | Common Stock | 4,000 | 23,062 | D |
Explanation of responses
- F1The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning October 23, 2007.